SlideShare a Scribd company logo
1 of 15
By Prandeep Borah
MSF Pharmacy, GFSU
 Recalls are actions taken by a firm to remove a product
from the market.
 Recalls may be conducted on the basis of
 a firm's own initiative,
 by FDA request, or
 by FDA order under statutory authority.
The guidance is intended to assist those
members of industry regulated by the
Food and Drug Administration (FDA) in
handling all aspects of a product recall,
including all corrections and removals.
 1. Class I recalls have a reasonable probability that the use
of the product or exposure to the product will cause
serious, adverse health consequences or death.
 An example of a Class I recall is a label mix-up of two
potent drugs or a defective replacement heart valve. The
recall should include all stocks of the two drugs in
pharmacies with notification of all patients who received
the product.
 If the recall involves heart valves ,all hospitals and all
heart valve recepients would receive notification.
 2. Class II recalls involve products that the use of the
product or exposure to the product may cause
temporary or medically reversible health consequences
or where probability of serious harm is remote.
 An example of a Class II recall is a sub potent drug
product. The recall usually includes the stocks of drugs
in pharmacies.
 3. Class III recalls involve the use of or exposure to
product that is not likely to cause adverse health
consequences.
 An example of a Class III recall is inclusion of material
not intended for inclusion in the product such as dirt,
plastic, animal parts.
 Market withdrawal:
Occurs when a product has a minor violation that would not be
subject to FDA legal action. The firm removes the product from
the market or corrects the violation. For example, a product
removed from the market due to tampering, without evidence of
manufacturing or distribution problems, would be a market
withdrawal.
 Medical device safety alert:
Issued in situations where a medical device may present an
unreasonable risk of substantial harm. In some case, these
situations also are considered recalls.
 It is recommended to submit the information to local FDA District
Recall Coordinator as soon as possible after the decision to recall is made
not waiting to submit information until ALL applicable information is
prepared
Recommend to include the following information in your
recall submission
 PRODUCT INFORMATION:
Product name
Description of the product; Dosage form, indication
 TWO COMPLETE SETS OF ALL Product labeling
Individual package label
Package Inserts
 CODES (Production Identification Numbers):
* Lot/Unit Numbers
 RECALLING FIRM:
Firm name, address
CONTACTS for Recalling Firm: Name/title/phone/fax
number/e-mail
 MANUFACTURER:
* Firm name, address, city, state, zip code
* FDA registration number
 REASON FOR THE RECALL:
Explain in detail how product is defective and/or violative.
 Explain how the defect affects the performance and safety of
the product
 If the recall is due to the presence of a contaminant (cleaning fluid,
machine oil, paint), explain level of contaminant in the product.
 If the recall is due to failure of the product to meet product
specifications, provide the specifications and report all test results.
Provide copies of any sample analysis.
 If the recall is due to a label/ingredient issue, provide correct and
incorrect labels.
 Please explain how the problem occurred and the date (s) it
occurred.
 Explain how the problem was discovered and the date discovered.
 Provide detailed information on complaints associated with the
product.
 HEALTH HAZARD ASSESSMENT
 VOLUME OF RECALLED PRODUCT
Total quantity produced ;
Date (s) produced ;
Quantity distributed
Estimate amount remaining in marketplace
distributor level ;retail ;user level
 DISTRIBUTION PATTERN :
wholesalers/distributors ; repackers
manufacturers ; retail/pharmacy ;foreign consignees
 Provide a consignee list (names/address/city/state/contact
name/phone number) to the local District Recall Coordinator
 RECALL STRATEGY:
Indicate the level in the distribution chain to which you
are extending the recall. (i.e. wholesale/retail.)
Indicate the method of notification (i.e. mail, phone,
facsimile, e-mail).
Indicate how letters will be sent to customers .
Report on what you have instructed customers to do
with the recalled product .
Report on recall effectiveness check strategy.
 Public Notification
In a situation where the product may pose a significant health
hazard and recalled product is in the hands of consumers, a
press release is usually appropriate. Include the following
information in a recall notification
 PRODUCT IDENTIFICATION:
DESCRIPTION OF THE PROBLEM: codes used to identify
the product, e.g. lot/unit numbers
 DEPTH OF THE RECALL:
The recall notification should clearly identify the depth to
which the recall is to extend (e.g. wholesale, retail, or user
level
 INSTRUCTIONS TO CUSTOMERS
 EFFECTIVENESS OF THE RECALL:
It is the recalling firm’s responsibility to assure that the recall
is effective. Therefore, we recommend that you consider
effectiveness checks for every recall.
 RECALL STATUS REPORTS: to your local District Recall
Coordinator
 ROOT CAUSE OF THE PROBLEM THAT RESULTED IN
THE RECALL:
 CORRECTIVE ACTIONS TO PREVENT FUTURE
OCCURRENCES OF THE PROBLEM:
In the fall of 1982, seven
people in the Chicago area
died after ingesting Extra-
Strength Tylenol laced with
potassium cyanide. Sparked a
citywide panic; for days,
police cruised the streets,
blaring warnings that
residents should discard the
product.
Johnson & Johnson spent
millions of dollars recalling
Tylenol from stores
nationwide.
THANK YOU

More Related Content

What's hot

BATCH MANUFACTURING RECORD
BATCH MANUFACTURING RECORDBATCH MANUFACTURING RECORD
BATCH MANUFACTURING RECORDchandamalviya
 
Pharmaceutical validation & it's types
 Pharmaceutical validation & it's types Pharmaceutical validation & it's types
Pharmaceutical validation & it's typesAlexa Jacob
 
Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)ShrutiBattinwar
 
Schedule M in pharmaceutical industries
Schedule M in pharmaceutical industries Schedule M in pharmaceutical industries
Schedule M in pharmaceutical industries rasika walunj
 
Recall procedures
Recall proceduresRecall procedures
Recall proceduresSyeda Abeer
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004Patel Parth
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVSUJITHA MARY
 
THE ROLE OF QA IN PHARMACEUTICALS
THE ROLE OF QA IN PHARMACEUTICALSTHE ROLE OF QA IN PHARMACEUTICALS
THE ROLE OF QA IN PHARMACEUTICALSKostas Skopelitis
 
Quality control test: Containers, Closures and Secondary packing materials
Quality control test: Containers, Closures and  Secondary packing materialsQuality control test: Containers, Closures and  Secondary packing materials
Quality control test: Containers, Closures and Secondary packing materialsPranali Polshettiwar
 
Introduction to quality assurance and qualtiy control
Introduction to quality assurance and qualtiy controlIntroduction to quality assurance and qualtiy control
Introduction to quality assurance and qualtiy controlAmruta Balekundri
 
Document Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical IndustryDocument Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical IndustryNAKUL DHORE
 
Technology Transfer in Pharma Industry
Technology Transfer in Pharma IndustryTechnology Transfer in Pharma Industry
Technology Transfer in Pharma Industrynaseebbasha
 
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCTCopp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCTSuraj Pamadi
 

What's hot (20)

BMR & MFR
BMR & MFRBMR & MFR
BMR & MFR
 
Documentation...
Documentation...Documentation...
Documentation...
 
BATCH MANUFACTURING RECORD
BATCH MANUFACTURING RECORDBATCH MANUFACTURING RECORD
BATCH MANUFACTURING RECORD
 
Complaints
Complaints Complaints
Complaints
 
Pharmaceutical validation & it's types
 Pharmaceutical validation & it's types Pharmaceutical validation & it's types
Pharmaceutical validation & it's types
 
Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)Complaints (QUALITY ASSURANCE)
Complaints (QUALITY ASSURANCE)
 
Ipqc for tablets
Ipqc for tablets Ipqc for tablets
Ipqc for tablets
 
Schedule M in pharmaceutical industries
Schedule M in pharmaceutical industries Schedule M in pharmaceutical industries
Schedule M in pharmaceutical industries
 
Recall procedures
Recall proceduresRecall procedures
Recall procedures
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004
 
COMPLAINTS. UNIT IV
COMPLAINTS. UNIT IVCOMPLAINTS. UNIT IV
COMPLAINTS. UNIT IV
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Good warehouse practice
Good warehouse practiceGood warehouse practice
Good warehouse practice
 
THE ROLE OF QA IN PHARMACEUTICALS
THE ROLE OF QA IN PHARMACEUTICALSTHE ROLE OF QA IN PHARMACEUTICALS
THE ROLE OF QA IN PHARMACEUTICALS
 
Quality control test: Containers, Closures and Secondary packing materials
Quality control test: Containers, Closures and  Secondary packing materialsQuality control test: Containers, Closures and  Secondary packing materials
Quality control test: Containers, Closures and Secondary packing materials
 
Introduction to quality assurance and qualtiy control
Introduction to quality assurance and qualtiy controlIntroduction to quality assurance and qualtiy control
Introduction to quality assurance and qualtiy control
 
Document Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical IndustryDocument Maintenance in Pharmaceutical Industry
Document Maintenance in Pharmaceutical Industry
 
Technology Transfer in Pharma Industry
Technology Transfer in Pharma IndustryTechnology Transfer in Pharma Industry
Technology Transfer in Pharma Industry
 
BMR And MFR
BMR And MFRBMR And MFR
BMR And MFR
 
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCTCopp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
Copp - CERTIFICATE OF PHARMACEUTICAL PRODUCT
 

Similar to Pharmaceutical product recall

Recall of ph product
Recall of ph productRecall of ph product
Recall of ph productAhmed Suhail
 
FDA requested recall & Firm's initiative recall
FDA requested recall & Firm's initiative recallFDA requested recall & Firm's initiative recall
FDA requested recall & Firm's initiative recallAshishVerma593
 
Compl n recal 112070804013
Compl n recal  112070804013Compl n recal  112070804013
Compl n recal 112070804013Patel Parth
 
drugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptxdrugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptxMonishabasavaraj
 
Fda med watch
Fda med watchFda med watch
Fda med watchSridhar S
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugscomplianceonline123
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugsFda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugsComplianceOnline
 
Labelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotechLabelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotechBindu Kshtriya
 
Pharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsPharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsSatheesh Kadiam
 
My Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device RegulationsMy Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device RegulationsHarshit Thakkar
 
Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014Ceuta Healthcare
 
Labeling in pharmaceutical packaging
Labeling in pharmaceutical packagingLabeling in pharmaceutical packaging
Labeling in pharmaceutical packagingRohit kumar
 
Drug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana raoDrug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana raoGandrapuSpandanarao
 
COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to KnowCOVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to KnowEMMAIntl
 
COMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical productsCOMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical productsLINGESHMASSLEE007
 
Claims involving defective medical devices
Claims involving defective medical devicesClaims involving defective medical devices
Claims involving defective medical deviceskrish stha
 

Similar to Pharmaceutical product recall (20)

Recall of ph product
Recall of ph productRecall of ph product
Recall of ph product
 
Product recall overview
Product recall overviewProduct recall overview
Product recall overview
 
FDA requested recall & Firm's initiative recall
FDA requested recall & Firm's initiative recallFDA requested recall & Firm's initiative recall
FDA requested recall & Firm's initiative recall
 
Compl n recal 112070804013
Compl n recal  112070804013Compl n recal  112070804013
Compl n recal 112070804013
 
drugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptxdrugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptx
 
RECALL.pptx
RECALL.pptxRECALL.pptx
RECALL.pptx
 
Fda med watch
Fda med watchFda med watch
Fda med watch
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements  for otc drugsFda adverse event reporting requirements  for otc drugs
Fda adverse event reporting requirements for otc drugs
 
Fda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugsFda adverse event reporting requirements for otc drugs
Fda adverse event reporting requirements for otc drugs
 
Labelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotechLabelling of drugs cosmetics nd biotech
Labelling of drugs cosmetics nd biotech
 
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
Fda guidance for pharmaceutical post marketing reporting   professor pirouziFda guidance for pharmaceutical post marketing reporting   professor pirouzi
Fda guidance for pharmaceutical post marketing reporting professor pirouzi
 
Pharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT TeamsPharmaceutical Industry - Business Perspectives for IT Teams
Pharmaceutical Industry - Business Perspectives for IT Teams
 
My Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device RegulationsMy Presentation on Mexico Medical Device Regulations
My Presentation on Mexico Medical Device Regulations
 
Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014Ceuta Pharmacovigilance Presentation 2014
Ceuta Pharmacovigilance Presentation 2014
 
Labeling in pharmaceutical packaging
Labeling in pharmaceutical packagingLabeling in pharmaceutical packaging
Labeling in pharmaceutical packaging
 
Drug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana raoDrug Regulatory Affairs, PPT by Sirisha Spandana rao
Drug Regulatory Affairs, PPT by Sirisha Spandana rao
 
COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to KnowCOVID-19 and the FDA: What Every Manufacturing Company Needs to Know
COVID-19 and the FDA: What Every Manufacturing Company Needs to Know
 
COMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical productsCOMPLAINTS on quality of pharmaceutical products
COMPLAINTS on quality of pharmaceutical products
 
Post operational activities
Post operational activitiesPost operational activities
Post operational activities
 
Claims involving defective medical devices
Claims involving defective medical devicesClaims involving defective medical devices
Claims involving defective medical devices
 

Recently uploaded

Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...ZurliaSoop
 
Third Battle of Panipat detailed notes.pptx
Third Battle of Panipat detailed notes.pptxThird Battle of Panipat detailed notes.pptx
Third Battle of Panipat detailed notes.pptxAmita Gupta
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...pradhanghanshyam7136
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Magic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptxMagic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptxdhanalakshmis0310
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 

Recently uploaded (20)

Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Third Battle of Panipat detailed notes.pptx
Third Battle of Panipat detailed notes.pptxThird Battle of Panipat detailed notes.pptx
Third Battle of Panipat detailed notes.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Magic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptxMagic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 

Pharmaceutical product recall

  • 1. By Prandeep Borah MSF Pharmacy, GFSU
  • 2.  Recalls are actions taken by a firm to remove a product from the market.  Recalls may be conducted on the basis of  a firm's own initiative,  by FDA request, or  by FDA order under statutory authority. The guidance is intended to assist those members of industry regulated by the Food and Drug Administration (FDA) in handling all aspects of a product recall, including all corrections and removals.
  • 3.  1. Class I recalls have a reasonable probability that the use of the product or exposure to the product will cause serious, adverse health consequences or death.  An example of a Class I recall is a label mix-up of two potent drugs or a defective replacement heart valve. The recall should include all stocks of the two drugs in pharmacies with notification of all patients who received the product.  If the recall involves heart valves ,all hospitals and all heart valve recepients would receive notification.
  • 4.  2. Class II recalls involve products that the use of the product or exposure to the product may cause temporary or medically reversible health consequences or where probability of serious harm is remote.  An example of a Class II recall is a sub potent drug product. The recall usually includes the stocks of drugs in pharmacies.
  • 5.  3. Class III recalls involve the use of or exposure to product that is not likely to cause adverse health consequences.  An example of a Class III recall is inclusion of material not intended for inclusion in the product such as dirt, plastic, animal parts.
  • 6.  Market withdrawal: Occurs when a product has a minor violation that would not be subject to FDA legal action. The firm removes the product from the market or corrects the violation. For example, a product removed from the market due to tampering, without evidence of manufacturing or distribution problems, would be a market withdrawal.  Medical device safety alert: Issued in situations where a medical device may present an unreasonable risk of substantial harm. In some case, these situations also are considered recalls.  It is recommended to submit the information to local FDA District Recall Coordinator as soon as possible after the decision to recall is made not waiting to submit information until ALL applicable information is prepared
  • 7. Recommend to include the following information in your recall submission  PRODUCT INFORMATION: Product name Description of the product; Dosage form, indication  TWO COMPLETE SETS OF ALL Product labeling Individual package label Package Inserts  CODES (Production Identification Numbers): * Lot/Unit Numbers
  • 8.  RECALLING FIRM: Firm name, address CONTACTS for Recalling Firm: Name/title/phone/fax number/e-mail  MANUFACTURER: * Firm name, address, city, state, zip code * FDA registration number  REASON FOR THE RECALL: Explain in detail how product is defective and/or violative.  Explain how the defect affects the performance and safety of the product
  • 9.  If the recall is due to the presence of a contaminant (cleaning fluid, machine oil, paint), explain level of contaminant in the product.  If the recall is due to failure of the product to meet product specifications, provide the specifications and report all test results. Provide copies of any sample analysis.  If the recall is due to a label/ingredient issue, provide correct and incorrect labels.  Please explain how the problem occurred and the date (s) it occurred.  Explain how the problem was discovered and the date discovered.  Provide detailed information on complaints associated with the product.
  • 10.  HEALTH HAZARD ASSESSMENT  VOLUME OF RECALLED PRODUCT Total quantity produced ; Date (s) produced ; Quantity distributed Estimate amount remaining in marketplace distributor level ;retail ;user level  DISTRIBUTION PATTERN : wholesalers/distributors ; repackers manufacturers ; retail/pharmacy ;foreign consignees  Provide a consignee list (names/address/city/state/contact name/phone number) to the local District Recall Coordinator
  • 11.  RECALL STRATEGY: Indicate the level in the distribution chain to which you are extending the recall. (i.e. wholesale/retail.) Indicate the method of notification (i.e. mail, phone, facsimile, e-mail). Indicate how letters will be sent to customers . Report on what you have instructed customers to do with the recalled product . Report on recall effectiveness check strategy.
  • 12.  Public Notification In a situation where the product may pose a significant health hazard and recalled product is in the hands of consumers, a press release is usually appropriate. Include the following information in a recall notification  PRODUCT IDENTIFICATION: DESCRIPTION OF THE PROBLEM: codes used to identify the product, e.g. lot/unit numbers  DEPTH OF THE RECALL: The recall notification should clearly identify the depth to which the recall is to extend (e.g. wholesale, retail, or user level
  • 13.  INSTRUCTIONS TO CUSTOMERS  EFFECTIVENESS OF THE RECALL: It is the recalling firm’s responsibility to assure that the recall is effective. Therefore, we recommend that you consider effectiveness checks for every recall.  RECALL STATUS REPORTS: to your local District Recall Coordinator  ROOT CAUSE OF THE PROBLEM THAT RESULTED IN THE RECALL:  CORRECTIVE ACTIONS TO PREVENT FUTURE OCCURRENCES OF THE PROBLEM:
  • 14. In the fall of 1982, seven people in the Chicago area died after ingesting Extra- Strength Tylenol laced with potassium cyanide. Sparked a citywide panic; for days, police cruised the streets, blaring warnings that residents should discard the product. Johnson & Johnson spent millions of dollars recalling Tylenol from stores nationwide.